Moreover, high PDCD2L expression also indicated unfavorable diseases free survival in ACC (P = 0.039), BLCA (P = 0.048), CESC (P = 0.014), KIRC (P = 0.031), KIRP (P = 0.041), LGG (P = 0.043), LIHC (P = 0.021), and UVM (P = 0.016). This evidence concerns the gene PDCD2L and adrenal cortex carcinoma.